Tejas Trivedi Portfolio in 2025
Tejas Trivedi is an experienced investor and a key figure in India’s financial industry. He holds a well-diversified portfolio spread across several high-potential sectors. He shows strategic insights into both Indian and global markets. His investment choices reflect his strong understanding of business fundamentals, sectoral growth prospects, and risk management. His portfolio includes established companies along with emerging sectors. This approach mirrors his long-term vision for wealth creation. This blog covers Tejas Trivedi’s stock portfolio in 2025 and analyses the companies he holds along with how these investments align with his broader strategic approach.
Tejas Trivedi Portfolio Holdings List 2025
Here’s an overview of Tejas Trivedi’s key investments in 2025, along with their market performance and the current value of his holdings:
Company | Quantity Held | Holding Value (in Cr) |
---|---|---|
AstraZeneca Pharma India Ltd. | 5.08% | ₹114.5 Cr |
K.C. Denim Ltd. | 3.24% | ₹16.6 Cr |
D-Link (India) Ltd. | 3.11% | ₹11.5 Cr |
NOCIL Ltd. | 3.13% | ₹94.4 Cr |
Ind-Rubber Ltd. | 3.52% | ₹2.4 Cr |
Atul Ltd. | 1.08% | ₹18.3 Cr |
Thirumalai Chemicals Ltd. | 1.81% | ₹7.8 Cr |
Cosmo Ferrites Ltd. | 2.00% | ₹5.5 Cr |
Disclaimer: Please note that the above table is for educational purposes only, and is not recommendatory. Please do your own research or consult your financial advisor before investing. The data is derived from Tickertape Stock Screener and is subject to real-time updates.
Who is Tejas Trivedi?
Tejas Trivedi has decades of experience in India’s capital markets. He is one of the top investors in India and began his career in equity research at firms such as Corporate Database and Anvil Group. Today, he stands as a prominent figure in the business and investment sectors. He establishes his investment approach on analysis, sectoral diversification, and long-term growth. He also follows a disciplined method of managing risk and identifies companies with high potential across different industries.
Tejas Trivedi’s Key Portfolio Stocks
- AstraZeneca Pharma India Ltd.: AstraZeneca Pharma India Ltd. develops innovative medicines in oncology, cardiovascular, renal, respiratory, and inflammation segments. The company holds a strong market presence by driving research-based drug development and focusing on patient-centric healthcare solutions.
- K.C. Denim Ltd.: K.C. Denim Ltd. produces high-quality denim fabric for the textile industry. The company focuses on innovation and sustainability while meeting global demand in the evolving apparel and fashion sectors.
- D-Link (India) Ltd.: D-Link (India) Ltd. provides networking products and services such as routers, switches, and wireless solutions. It supports both home and business networking with reliable and scalable connectivity in the digital space.
- NOCIL Ltd.: NOCIL Ltd. manufactures rubber chemicals that serve tyre production and other rubber goods. The company contributes to the global supply chain by offering sustainable and high-quality chemical solutions to various industries.
- Indag Rubber Ltd.: Indag Rubber Ltd. manufactures rubber products for multiple industrial applications. The company serves automotive, machinery, and other sectors with durable and precise rubber solutions.
Tejas Trivedi Shareholding: Sector-Wise Investments

- Pharmaceuticals: Trivedi holds a major stake in AstraZeneca Pharma India. He focuses on healthcare because it continues to grow.
- Textiles: He invests in K.C. Denim Ltd., showing his interest in the textile and apparel world.
- Technology: His shares in D-Link reflect his belief that technology will keep expanding.
- Chemicals and Industrial: Trivedi backs companies like NOCIL, Atul Ltd., and Thirumalai Chemicals. These show his strong focus on chemicals and industrial businesses.
- Rubber and Industrial Materials: He has a stake in Ind-Rubber Ltd., which points to his interest in special industrial materials.
This spread across sectors helps Trivedi control risk. It keeps him ready for growth in both old and new industries.
Tejas Trivedi’s Net Worth

By June 2025, his portfolio reached over ₹1,645.3 cr. The steady rise shows his knack for spotting good investments early, especially in sectors set to grow long-term.
Shares Purchased By Tejas Trivedi in 2025

These additions reflect Tejas Trivedi’s confidence in the long-term growth potential of these companies, particularly in textiles and pharmaceuticals, sectors with strong future prospects.
Shares Sold By Tejas Trivedi in 2025

The reductions in these positions suggest that Tejas Trivedi is rebalancing his portfolio, potentially to capitalise on better opportunities in other sectors or companies with stronger growth prospects.
Key Highlights of Tejas Trivedi’s Investment Strategy
- Diversified Portfolio: Tejas Trivedi invests across multiple sectors, including pharmaceuticals, technology, and chemicals. He manages risk and captures growth from different industries through holdings such as AstraZeneca Pharma and K.C. Denim.
- Long-Term Vision: Trivedi focuses on long-term growth stocks and invests in companies with strong fundamentals. He shows patience by holding investments like AstraZeneca Pharma and Atul Ltd. to benefit from steady sectoral growth.
- Selective Risk Management: Trivedi balances high-risk and low-risk assets in his portfolio. He manages volatility by carefully adjusting his holdings, which include companies such as D-Link and Cosmo Ferrites Ltd.
- Focus on Management Quality: Trivedi invests in companies with strong leadership. He considers capable management essential for overcoming challenges and sustaining long-term success, as reflected in his stake in AstraZeneca Pharma India Ltd.
- Research-Driven Approach: Trivedi bases his investments on in-depth research. He analyses financial health and market potential to ensure each stock fits within his long-term strategy.
Tejas Trivedi’s Investment Philosophy
Tejas Trivedi’s philosophy revolves around value investing, fundamentals, and long-term growth:
- Value Investing: Tejas Trivedi follows an approach based on value investing, fundamentals, and long-term growth. He targets companies that remain undervalued and looks for long-term appreciation instead of short-term gains.
- Focus on Fundamentals: He prioritises financial stability, growth potential, and strong management when choosing stocks.
- Patience: He holds his investments for long periods, which allows his portfolio to grow along with market cycles.
- Portfolio Diversification: He spreads his investments across sectors to reduce risk and maintain portfolio stability.
- Adaptability: He stays flexible and adjusts his portfolio to capture emerging opportunities while staying focused on long-term goals.
Conclusion
Tejas Trivedi’s portfolio highlights his skill in spotting companies with strong growth potential across different sectors. He invests strategically in firms like AstraZeneca Pharma, K.C. Denim, and Atul Ltd. to create value through researched and long-term holdings. He follows a strategy based on diversification, fundamental analysis, and risk management, which helps him build a resilient and sizable portfolio.
Frequently Asked Questions About Hemendra Kothari’s Portfolio
Tejas Trivedi is a seasoned investor with decades of experience in India’s capital markets. He is known for his deep analytical approach and successful investments in sectors like pharmaceuticals, chemicals, and technology.
AstraZeneca Pharma India Ltd. and Atul Ltd. are some of his best-performing stocks, reflecting his strong conviction in the pharmaceutical and chemical sectors.
As of mid-2025, Tejas Trivedi’s publicly held portfolio is valued at approximately ₹1,645.3 cr, a reflection of his strategic investments over the years.
Tejas Trivedi focuses on long-term growth, diversification, and strong management in the companies he invests in, with a particular focus on fundamentals and research.
AstraZeneca Pharma is a leader in the pharmaceutical industry, making it a strong investment due to its innovative treatments and growing market in India.